Tag: Vaccines
Overall Increase Seen in COVID-19 Vaccine Acceptance Globally
Vaccine hesitancy varied considerably; 12.1 percent of vaccinated individuals hesitant about booster doses
Waning Immunity Most Consistent With Recent Mumps Outbreaks
Estimated 32.8 percent of individuals lose vaccine-derived immunity by age 18 years in the United States
Free Spike Antigen ID’d in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
However, mRNA vaccine-induced immune responses did not differ for those who developed myocarditis and those who did not
Racial/Ethnic Variation Seen in COVID-19 Vaccination Status in Children
Non-Hispanic Asian children and adolescents have the highest vaccination coverage, followed by Hispanic/Latino children
Increasing Staff Vaccination at Nursing Homes Cuts COVID-19 Infections
Increase in vaccination rate linked to fewer COVID-19 cases and deaths among residents, cases among staff
Flu Vaccine 36 Percent Effective Against A(H3N2) in 2021/2022
All sequenced A(H3N2) viruses belonged to genetic group 3C.2a1b subclade 2a.2, which was antigenically different from 2021-2022 vaccine component
No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
Minor adverse events seen in 48.6 percent of patients, most often arm soreness and/or fatigue
Nurse-Driven Protocol Ups Pneumococcal Vaccination Rates
Findings for pneumococcal vaccine among immunosuppressed rheumatology patients
COVID-19 Booster mRNA Dose Increases Antibody Duration
Immunoglobulin G spike receptor binding domain antibody levels similar after primary series, booster dose
Fewer Symptoms for Mpox Infection Seen After Vaccination
Mpox cases that occurred in vaccinated individuals associated with lower percentage of hospitalization
